ABCG2 and osteosarcoma: On the other hand, the ABC transporters (including the ABCC3 and ABCB1 gene products) are transmembrane ATP-dependent efflux pumps that block chemotherapy drugs from entering osteosarcoma tumour cells, leading to poor outcomes and systemic toxicity [9,12,13].